Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Filipa C. Lynce"'
Autor:
Alejandra Hurtado de Mendoza, Sara Gómez Trillos, Marc Schwartz, Beth Peshkin, Heidi E. Hamilton, Katie Fiallos, Filipa C. Lynce, Susan Vadaparampil, Vanessa B. Sheppard, Lucile Adams-Campbell, Andrea Otero, Kristi Graves
Publikováno v:
Journal of Clinical and Translational Science, Vol 2, Pp 68-68 (2018)
OBJECTIVES/SPECIFIC AIMS: The overall goal of this project is to enhance the use of GCRA in Latina breast cancer survivors at high risk of hereditary breast and ovarian cancer to reduce disparities in GCRA uptake. The aims of the study are to (1) dev
Externí odkaz:
https://doaj.org/article/8c462d1308c248b2ada2b4074805e872
Autor:
Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger, Fei Shen, Christopher Chitambar, Rita Nanda, Carla Falkson, Filipa C Lynce, Christopher Gallagher, Claudine Isaacs, Marcelo Blaya, Elisavet Paplomata, Radhika Walling, Karen Daily, Reshma Mahtani, Michael A Thompson, Robert Graham, Maureen E Cooper, Dean C Pavlick, Lee A Albacker, Jeffery Gregg, Jeffery P Solzak, Yu-Hsiang Chen, Casey L Bales, Erica Cantor, Bradley A Hancock, Nawal Kassem, Paul Helft, Bert O'Neil, Anna Maria Storniolo, Sunil Badve, Kathy D Miller, Milan Radovich
Publikováno v:
Cancer Research. 82:PD9-10
Purpose: Patients with triple negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy (NAC) have high risk of recurrence with prior data suggesting improved outcomes with capecitabine. Targeted agents have demonstrated acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b6e07aa59291a5b928144d855484380
https://doi.org/10.1158/1538-7445.sabcs21-pd9-10
https://doi.org/10.1158/1538-7445.sabcs21-pd9-10